- Strategic partnership in Latin America extended to cover five additional products in therapeutic categories including oncology, pulmonary hypertension, and rare diseases.
- The current market size of the products included in the agreement exceeds USD 100 million.
Adalvo and SteinCares are pleased to announce the extension of their long-term strategic collaboration in Latin America. The companies have recently signed a basket deal for five products to be marketed and distributed in Latin America. The current market size of the products included in the deal exceeds USD 100 million.
These value-added products encompass a diverse range of segments, each catering to specific indications and fulfilling unique patient needs. The portfolio offers a broad list of therapeutic products, some of which include specialty medicine for oncology, pulmonary hypertension, and an exclusive collaboration for an orphan disease.
With this solid partnership, SteinCares and Adalvo continue to strengthen their position in Latin America, providing patients with high-quality and affordable treatment options.
We are absolutely thrilled to announce our continued collaboration with SteinCares, which marks a significant milestone in our partnership. This new agreement not only strengthens our efforts to deliver value-added medications worldwide but also places a special emphasis on the Latin American region. We are confident that this enhanced partnership will enable us to make a greater impact on the healthcare landscape and improve access to vital medications across the globe.
We are delighted about this increased collaboration with Adalvo, a strategic partnership that will allow us to enhance our product portfolio of innovative and cost-effective medicines. We are deeply committed to improving access to specialty medicines and believe this partnership is an important milestone in our journey to expand access to advanced and affordable healthcare in Latin America. We look forward to continuing to work with Adalvo to make a difference in the lives of millions of patients
The extension of its collaboration with Adalvo is a sign of SteinCares' strong partnerships with highly innovative pharmaceutical and biotechnology firms. SteinCares is an ideal strategic ally for companies looking to grow their business in Latin America; with a strong focus on specialty healthcare and in-depth knowledge of local market access, regulatory and tendering processes within the region, the company meets the highest quality standards. With operations in over 30 countries across Latin America and the Caribbean, SteinCares effectively maximizes the value of its partners' assets.
Disclaimer: Products which are subject to patent protection are currently not offered or made available in countries where patents are in force.